跳至主要内容
临床试验/JPRN-UMIN000030400
JPRN-UMIN000030400招募中未知

Multiinstitutional prospective interventional study of biomarkers to predict efficacy and prognosis after nivolumab in patients with previously treated advanced renal cell carcinoma. - Multiinstitutional prospective interventional study of biomarkers to predict efficacy and prognosis after nivolumab in patients with previously treated advanced renal cell carcinoma.

Kobe University Graduate School of Medicine0 个研究点目标入组 200 人开始时间: 2018年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who have been administered immune checkpoint inhibitors including nivolumab in the past Patients who have a history of malignant tumors other than renal cell carcinoma and are judged not to be cured Patients who are merging psychiatric symptoms or psychiatric disorders and considered difficult to participate in the study Patients decided not applicable for this study by physician

研究者

发起方
Kobe University Graduate School of Medicine

相似试验